Figures
- FIGURE 1
Percentage of adults that enrolled and completed pulmonary rehabilitation (PR) and cardiac rehabilitation (CR). *: p≤0.05. Percentages calculated from those that were assessed for PR or CR. CHF: chronic heart failure; COPD: chronic obstructive pulmonary disease.
Tables
- TABLE 1
Baseline demographics from completed pulmonary rehabilitation (PR) and cardiac rehabilitation (CR) audit datasets
PR CR n COPD (n=7223) n COPD+CHF (n=190) n CHF (n=29 861) n CHF+COPD (n=3576) Age (years) 7222 70.0 (64.0–76.0) 190 74.0 (68.0–80.0)* 29 861 72.0 (62.0–80.0) 3576 73.0 (66.0–79.0)* BMI (kg·m−2) 4775 26.8 (22.9–31.1) 123 27.8 (24.3–34.0)* 13 769 28.1 (24.9–32.4) 1501 27.9 (24.3–32.6)* Sex (male, %) 7223 3817 (52.8) 190 131 (68.9)* 29 638 20 168 (68.0) 3558 2442 (68.6) Ethnicity (White British, %) 7223 6357 (88.0) 190 166 (87.4) 29 861 21 181 (86.2) 3576 2552 (91.2)* Smoking status 7056 186 12 896 1507 Current (%) 1585 (22.5) 29 (15.6) 1148 (8.9) 276 (18.3)* Former (%) 5038 (71.4) 141 (75.8) 6336 (49.1) 1032 (68.5) Never (%) 433 (6.1) 16 (8.6) 5412 (42.0) 199 (13.2) MRC scale 7223 3 (3–4) 190 4 (3–4)* NA NYHA scale NA 2891 2 (2–3) 359 2 (2–3)* Diabetes (%) 7223 940 (13.0) 190 47 (24.7)* 29 861 9286 (31.1) 3576 1041 (29.1)* Stroke (%) 7223 286 (4.0) 190 13 (6.8) 29 861 2753 (9.2) 3576 329 (9.2) Osteoporosis (%) 7223 550 (7.6) 190 17 (8.9) 29 861 803 (2.7) 3576 133 (3.7)* Hypertension (%) 7223 2162 (29.9) 190 72 (37.9)* 29 861 14 916 (50.0) 3576 1599 (44.7)* ISWT (m) 3723 199.9 (134.4) 96 154.2 (103.5)* 2162 277.2 (152.6) 211 225.9 (138.8)* 6MWT (m) 2789 249.5 (114.9) 74 194.8 (101.0)* 2556 249.5 (119.3) 343 217.7 (105.0)* *: p≤0.05 Data presented as mean (standard deviation), frequency (%) or median (interquartile range). 6MWT: 6 min walk test; BMI: body mass index; CHF: chronic heart failure; COPD: chronic obstructive pulmonary disease; ISWT: incremental shuttle walk test; MRC: Medical Research Council dyspnoea scale; NA: not applicable; NYHA: New York Heart Association.
- TABLE 2
Propensity-matched pre and post data from pulmonary rehabilitation (PR) and cardiac rehabilitation (CR)
PR COPD (n=116) COPD+CHF (n=116) n Pre Post Effect size n Pre Post Effect size ISWT (m) 41 173.9 (135.8) 233.2 (151.6)* 0.4 39 163.0 (115.4) 200.4 (128.4)* 0.3 6MWT (m) 19 233.0 (97.8) 281.2 (101.9)* 0.5 22 220.0 (89.8) 264.0 (110.0)* 0.5 CRQ–dyspnoea 33 2.7 (1.5) 3.6 (1.4)* 0.6 30 2.7 (1.1) 3.6 (1.4)* 0.8 CRQ–fatigue 33 3.8 (1.4) 4.4 (1.4)* 0.4 30 3.2 (1.5) 3.9 (1.4)* 0.5 CRQ–emotion 33 4.4 (1.3) 5.1 (1.2)* 0.5 30 4.5 (1.4) 5.1 (1.4)* 0.4 CRQ–mastery 33 4.5 (1.3) 5.2 (1.4)* 0.5 30 4.2 (1.4) 5.2 (1.5)* 0.7 CAT 38 21.0 (8.3) 15.9 (7.4)* 0.6 31 21.1 (8.1) 17.3 (7.5)* 0.5 CR CHF (n=306) CHF+COPD (n=306) n Pre Post Effect size n Pre Post Effect size ISWT (m) 26 239.2 (90.6) 316.5 (109.6)* 0.9 17 293.5 (154.6) 351.8 (187.3)* 0.4 6MWT (m) 64 248.7 (124.7) 293.8 (102.1)* 0.4 45 247.8 (119.4) 286.6 (98.6)* 0.3 WC (cm) 64 101.6 (15.7) 101.9 (15.9) 0.02 34 106.4 (14.3) 104.7 (14.6)* 0.1 Systolic BP (mmHg) 172 126 (22.2) 126 (21.0) 0.02 122 121 (19.4) 122 (18.1) 0.1 Diastolic BP (mmHg) 173 70 (12.6) 69 (10.5) 0.1 122 68 (9.9) 69 (11.2) 0.1 Total cholesterol (mmol·L−1) 48 4.4 (1.12) 4.0 (0.84) 0.4 31 4.2 (1.51) 4.1 (1.25) 0.1 LDL (mmol·L−1) 22 2.5 (0.85) 2.1 (0.67) 0.4 13 2.1 (0.77) 2.4 (0.97) 0.3 HDL (mmol·L−1) 33 1.2 (0.36) 1.3 (0.39) 0.1 19 1.2 (0.40) 1.2 (0.36) 0.1 HDL:LDL 27 3.8 (1.04) 3.6 (1.04) 0.2 15 3.5 (0.93) 3.7 (1.19) 0.2 TG (mmol·L−1) 23 1.3 (0.46) 1.3 (0.45) 0.00 14 1.6 (0.92) 1.6 (0.72) 0.00 HbA1c (%) 11 48.6 (10.78) 46.6 (8.31) 0.2 8 55.6 (19.87) 47.4 (10.91) 0.4 HADS–anxiety 138 5.7 (4.4) 4.9 (3.9)* 0.2 82 5.6 (3.6) 5.3 (3.5) 0.1 HADS–depression 138 6.1 (3.8) 4.6 (3.5)* 0.4 82 6.0 (3.6) 4.9 (3.3)* 0.3 Minnesota 54 39.8 (20.4) 33.5 (21.5)* 0.3 32 39.0 (24.3) 32.3 (19.6)* 0.3 *: p≤0.05. Data presented as mean (standard deviation). 6MWT: 6-min walk test; BP: blood pressure; CAT: COPD Assessment Test; CHF: chronic heart failure; COPD: chronic obstructive pulmonary disease; CRQ: Chronic Respiratory Questionnaire; HADS: Hospital Anxiety and Depression Scale; HbA1c: glycated haemoglobin; HDL: high-density lipoprotein; ISWT: incremental shuttle walk test; LDL: low-density lipoprotein; Minnesota: Minnesota Living with Heart Failure questionnaire; NA: not applicable; TG: triglycerides; WC: waist circumference.
Supplementary Material
Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.
Supplementary material 00131-2022.SUPPLEMENT
